Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Thomas Witzig"'
Autor:
Steven Hwang, Jacqueline Wang, Zizhong Tian, Xinyue Qi, Yi Jiang, Shijia Zhang, Richard C. Godby, Sameer Parikh, Wei Ding, Paul Hampel, Javier Munoz, Jonas Paludo, Saad Kenderian, Eli Muchtar, Mazie Tsang, Talal Hilal, Jose Leis, Gita Thanarajasingam, David Inwards, Grzegorz S. Nowakowski, Stephen Ansell, Thomas Habermann, Thomas Witzig, Neil Kay, Shouhao Zhou, Yucai Wang
Publikováno v:
HemaSphere, Vol 7, p e47546cf (2023)
Externí odkaz:
https://doaj.org/article/a53304fbac5b406782ef85c7a2a067cd
Autor:
Allison Bock, Raphael Mwangi, Fatemeh Ataei, Matthew Thorpe, Matthew Maurer, Josh Pritchett, Jacob Shreve, Jonas Paludo, James Cerhan, Arushi Khurana, Thomas Witzig, Thomas Habermann, Yucai Wang, Grzegorz S. Nowakowski, Jason Young
Publikováno v:
HemaSphere, Vol 7, p e6583552 (2023)
Externí odkaz:
https://doaj.org/article/25e8a438e9a74635a82733d488e1570d
Autor:
Carla Casulo, Armando Santoro, Guillaume Cartron, Kiyoshi Ando, Javier Munoz, Steven Le Gouill, Koji Izutsu, Simon Rule, Pieternella Lugtenburg, Jia Ruan, Luca Arcaini, Marie‐Laure Casadebaig, Brian Fox, Nurgul Kilavuz, Nils Rettby, Justine Dell'Aringa, Lilia Taningco, Richard Delarue, Myron Czuczman, Thomas Witzig
Publikováno v:
Cancer Reports, Vol 6, Iss 1, Pp n/a-n/a (2023)
Abstract Background Studies suggest that immune checkpoint inhibitors may represent a promising strategy for boosting immune responses and improving the antitumor activity of standard therapies in patients with relapsed/refractory hematologic maligna
Externí odkaz:
https://doaj.org/article/53982eb6c7094c0dbc546b6a65f550a0
Autor:
Ryan M. Carr, Denis Vorobyev, Terra Lasho, David L. Marks, Ezequiel J. Tolosa, Alexis Vedder, Luciana L. Almada, Andrey Yurcheko, Ismael Padioleau, Bonnie Alver, Giacomo Coltro, Moritz Binder, Stephanie L. Safgren, Isaac Horn, Xiaona You, Eric Solary, Maria E. Balasis, Kurt Berger, James Hiebert, Thomas Witzig, Ajinkya Buradkar, Temeida Graf, Peter Valent, Abhishek A. Mangaonkar, Keith D. Robertson, Matthew T. Howard, Scott H. Kaufmann, Christopher Pin, Martin E. Fernandez-Zapico, Klaus Geissler, Nathalie Droin, Eric Padron, Jing Zhang, Sergey Nikolaev, Mrinal M. Patnaik
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-18 (2021)
Chronic myelomonocytic leukaemia is classified as proliferative (pCMML) or dysplastic based on the white blood cell counts but biological differences are unclear. Here, the authors show genetic, transcriptomic and epigenomic differences between these
Externí odkaz:
https://doaj.org/article/76c77b395be34b1d8dcd36a45fbde44e
Autor:
Hyo Jin Kim, Thomas Witzig, Stephen M Ansell, N Nora Bennani, Levi D Pederson, Pamela J Atherton, Ivana N Micallef, Gita Thanarajasingam, Grzegorz S Nowakowski, Andrew L Feldman
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 6 (2022)
Externí odkaz:
https://doaj.org/article/75cd9758e6834d9a94a1052256777d1e
Autor:
Surbhi Sidana, Cristine Allmer, Melissa C. Larson, Amylou Dueck, Kathleen Yost, Rahma Warsame, Gita Thanarajasingam, James R. Cerhan, Jonas Paludo, S. Vincent Rajkumar, Thomas M. Habermann, Grzegorz S. Nowakowski, Yi Lin, Morie A. Gertz, Thomas Witzig, Angela Dispenzieri, Wilson I. Gonsalves, Stephen M. Ansell, Carrie A. Thompson, Shaji K. Kumar
Publikováno v:
JCO oncology practice. 18(8)
PURPOSE: Patients' concerns regarding clinical trial (CT) participation include apprehension about side effects, quality of life (QoL), financial burden, and quality of care. METHODS: We prospectively evaluated the experience of patients with multipl
Autor:
Nicole McLaughlin, Yucai Wang, Thomas Witzig, Jose Villasboas, Thomas Habermann, David Inwards, Nora Bennani, Gita Thanarajasingam, Grzegorz Nowakowski, Luis Porrata, Carrie Thompson, Ivana Micallef, Patrick Johnston, Stephen Ansell, Jonas Paludo
Publikováno v:
Leukemia & Lymphoma. 64:371-377
Involvement of the central nervous system (CNS) is a rare complication of mantle cell lymphoma (MCL) with limited treatment options. We report the outcomes of 36 patients with CNS involvement compared to 72 matched control MCL patients without CNS in
Autor:
Kristine Broglio, Lale Kostakoglu, Carol Ward, Federico Mattiello, Denis Sahin, Tina Nielsen, Anna McGlothlin, Corrine F. Elliott, Thomas Witzig, Laurie H. Sehn, Marek Trnĕný, Umberto Vitolo, Maurizio Martelli, Margaret Foster, Barbara Wendelberger, Grzegorz Nowakowski, Donald A. Berry
Publikováno v:
Leukemia & Lymphoma. 63:2816-2831
This study's focus is the association of end-of-therapy (EOT) PET results with progression-free (PFS) and overall survival (OS) in patients with diffuse large B-cell lymphoma receiving first-line chemoimmunotherapy. We develop a Bayesian hierarchical
Autor:
Michael A. Barry, Thomas Witzig, Philip Greipp, Diane F. Jelinek, Shannon M. May, Eric A. Weaver, Julien S. Senac, Christopher Y. Chen
Purpose: Oncolytic viruses are self-amplifying anticancer agents that make use of the natural ability of viruses to kill cells. Adenovirus serotype 5 (Ad5) has been extensively tested against solid cancers, but less so against B-cell cancers because
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12d3b1a569675d5ae41a9cb222db5628
https://doi.org/10.1158/1078-0432.c.6519689
https://doi.org/10.1158/1078-0432.c.6519689
Autor:
Michael A. Barry, Thomas Witzig, Philip Greipp, Diane F. Jelinek, Shannon M. May, Eric A. Weaver, Julien S. Senac, Christopher Y. Chen
PDF file - 233KB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38171fc1f47c59b1966591aff27c324c
https://doi.org/10.1158/1078-0432.22443140
https://doi.org/10.1158/1078-0432.22443140